Circulating BAFF and CXCL10 levels predict response to pegylated interferon in patients with HBeAg-positive chronic hepatitis B.
Sign Up to like & getrecommendations! Published in 2019 at "Asian Pacific journal of allergy and immunology"
DOI: 10.12932/ap-050718-0365
Abstract: BACKGROUND B-cell activating factor (BAFF), an essential cytokine for B lymphocytes activation, has been implicated in the pathogenesis of chronic viral hepatitis. However, the role of BAFF in patients with chronic hepatitis B (CHB) undergoing… read more here.
Keywords: cxcl10; treatment; patients hbeag; baff ... See more keywords